Nuvisan GmbH

Neu-Ulm 25 trials 3 recruiting

25 Registered trials

3 Currently recruiting

Organisation

Nuvisan GmbH

Location

Neu-Ulm, Germany

Identifier

ORG-100011873

Address

Wegenerstrasse 13, Ludwigsfeld, 89231, Germany

Departments

Clincal Service
Clinic
Clinical Operations
Clinical Services
Patient Visits

Clinical trials at this site (25)

Search interface

A study to learn about how different drugs interact with each drug in a new 7-drug mixture as they move into, through, and out of the body i… Pending

2023-504870-39-00 drug-drug interactions (DDI) 3
Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared… Pending

2025-521830-27-00 Post-bariatric hypoglycaemia 3
Study in healthy volunteers to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as a single intravenous inject… Pending

2025-522244-40-00 It is used to treat symptomatic anaemia in chronic rena 3
Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous… Pending

2025-522246-43-00 Treatment of symptomatic anemia associated with chronic 3
Phase I Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine Pending

2026-526168-19-00 Gonorrhea 1
A study to learn about the amount of asundexian in the blood and the effect of food on its levels when healthy participants take it as adult… Recruiting

2025-523677-41-00 Prevention of thromboembolic events 3 2026-05-06
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Recruiting

2024-513069-37-00 Healthy 1 2026-01-30
A first-in-human study to learn about how safe BAY 3620122 is, how much of it gets absorbed in the blood, and how it affects the body of hea… Recruiting

2025-523301-15-00 Vasodilatory shock 1 2025-12-17
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine… Halted

2023-504215-32-00 Overweight and obesity 9 2023-09-28
Crossover study to investigate the safety and tolerability as well as the blood levels after three single doses of Tacrolimus, of which 2 ar… Ended

2025-525076-29-00 Phase I study in healthy male volunteers. Intended indi 3 2026-03-23
A study to find out whether the medication pasireotide is absorbed and processed the same way when given under the skin using either a reusa… Ended

2024-519165-22-00 Post-bariatric hypoglycaemia 3 2025-11-04
A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy V… Ended

2024-519316-13-00 Phase I study in healthy male and female volunteers. In 1 2025-08-01
A first-in-human study to learn about how safe the study drug is in healthy participants Ended

2024-517512-30-00 Cardiac arrhythmia 1 2025-04-28
A study to learn about how itraconazole affects the level of emodepside in the blood when emodepside is given as a new type of tablet to hea… Ended

2024-515757-24-00 Soil-transmitted helminth infection 3 2025-02-04
A Phase 1, multiple-dose, single-center, randomized, open-label, 2-period, 2-treatment crossover systemic bioavailability study of diclofena… Ended

2024-515954-26-00 Phase I Study in healthy male and female volunteers. In 3 2024-11-19
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants Ended

2024-512841-17-00 Healthy 3 2024-09-04
Evaluation of vamorolone CYP3A4 induction on midazolam (a sensitive CYP3A4 substrate) pharmacokinetics Ended

2024-513845-36-00 Phase I study in healthy male volunteers. Intended indi 3 2024-08-13
A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together Ended

2023-509488-26-00 Prevention of ischemic stroke in patients after an acut 3 2024-07-18
A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male particip… Ended

2024-512101-60-00 Phase I study in healthy male volunteers. Intended indi 3 2024-06-05
A study to learn about how much emodepside gets absorbed in the blood and how food affects its absorption when given as a new type of tablet… Ended

2023-508905-26-00 Onchocerciasis (river blindness): is an infectious dise 3 2024-05-06
A study to learn how much elinzanetant gets into the blood, how safe it is and how it affects the body after taking single and multiple amou… Ended

2023-503864-17-00 Vasomotor Symptoms as a sex hormone-dependent disorder 3 2023-09-20
A study to learn how safe the study treatment BAY2701250 is, how it affects the body and how it moves into, through and out of the body in h… Ended

2023-503368-18-00 Pulmonary hypertension due to left heart disease 1 2023-09-14
A first in human single dose escalation study to investigate the safety, tolerability, pharmacokinetics, and pharmcodynamics of BAY 3389934 … Ended

2022-502866-25-00 Sepsis associated disseminated intravascular coagulatio 1 2023-08-18
A two-part, open-label study to assess the pharmacokinetics, pharmacodynamics and safety of single doses of inhaled and intravenously admini… Ended

2022-503037-63-00 Phase I, Clinical trial in healthy males and females in 3 2023-08-17